Pacira BioSciences, Inc. (PCRX)

NMS – Real Time Price. Currency in USD

23.77

-0.61 (-2.50%)

Market open: Aug 12, 2026, 3:44 PM EDT

24.38

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 5:19 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

726M

701M

675M

667M

Cost of goods sold

-207M

-228M

-242M

-257M

Gross Profit

519M

473M

433M

410M

Operating expenses (excl. COGS)

-491M

-376M

-346M

-339M

Operating Income

28M

98M

87M

71M

Non-operating income, total

-11M

-161M

-26M

-58M

Pretax income

17M

-63M

62M

13M

Equity in earnings

Taxes

-10M

-36M

-20M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-100M

42M

16M

Discontinued operations

Net income

-100M

42M

16M

Dilution adjustment

Preferred dividends

Pacira BioSciences, Inc. (PCRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pacira BioSciences, Inc. (PCRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Pacira BioSciences, Inc. (PCRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pacira BioSciences, Inc. (PCRX)

Income Statement (Annual)

Income Statement (Annual)